Association of Shorter Leukocyte Telomere Repeat Length with Dementia and Mortality
Overview
Affiliations
Background: Shortening of chromosomal telomeres is a consequence of cell division and is a biological factor related to cellular aging and potentially to more rapid organismal biological aging.
Objective: To determine whether shorter telomere length (TL), as measured in human blood samples, is associated with the development of Alzheimer disease and mortality.
Design: We studied available stored leukocyte DNA from a community-based study of aging using realtime polymerase chain reaction analysis to determine mean TL in our modification of a method measuring the ratio of telomere sequence to single-copy gene sequence.
Setting: A multiethnic community-based study of aging and dementia.
Participants: One thousand nine hundred eighty-three subjects 65 years or older. Mean (SD) age at blood draw was 78.3 (6.9) years; at death, 86.0 (7.4) years. Median follow-up for mortality was 9.3 years; 190 (9.6%) developed incident dementia.
Results: The TL was inversely related to age and shorter in men than women. Persons dying during follow-up had a shorter TL compared with survivors (mean [SD], 6218 [819] vs 6491 [881] base pairs [bp] [P.001]), even after adjustment for age, sex, education, and apolipoprotein E genotype. Individuals who developed dementia had significantly shorter TL (mean [SD], 6131 [798] bp for prevalent cases and 6315 [817] bp for incident cases) compared with those remaining dementia-free (6431 [864] bp). Cox-regression analyses showed that shorter TL was a risk for earlier onset of dementia (P=.05), but stratified analyses for sex showed that this association of age at onset of dementia with shorter TL was significant in women only.
Conclusion: Our findings suggest that shortened leukocyte TL is associated with risks for dementia and mortality and may therefore be a marker of biological aging.
The relationship between telomere length and aging-related diseases.
Huang X, Huang L, Lu J, Cheng L, Wu D, Li L Clin Exp Med. 2025; 25(1):72.
PMID: 40044947 PMC: 11882723. DOI: 10.1007/s10238-025-01608-z.
Chan R, Huang C, Ng N, Tam H, Tam C, Cheng F Endocrinol Diabetes Metab. 2025; 8(2):e70030.
PMID: 39963020 PMC: 11833164. DOI: 10.1002/edm2.70030.
Advances in VNS efficiency and mechanisms of action on cognitive functions.
Wang W, Li R, Li C, Liang Q, Gao X Front Physiol. 2024; 15:1452490.
PMID: 39444752 PMC: 11496278. DOI: 10.3389/fphys.2024.1452490.
Fantecelle C, Polaco Covre L, Lopes P, Sarmento I, Decote-Ricardo D, Geraldo Freire de Lima C Clin Exp Immunol. 2024; 219(1).
PMID: 39428748 PMC: 11771187. DOI: 10.1093/cei/uxae088.
Kwiatkowska K, Anticoli S, Salvioli S, Calzari L, Gentilini D, Albano C Vaccines (Basel). 2024; 12(8).
PMID: 39204006 PMC: 11360008. DOI: 10.3390/vaccines12080880.